Free Trial

Guardian Pharmacy Services (NYSE:GRDN) Hits New 52-Week High - What's Next?

Guardian Pharmacy Services logo with Medical background

Key Points

  • Guardian Pharmacy Services shares reached a new 52-week high of $28.98, closing last at $28.72 with a trading volume of 392,473 shares.
  • Analyst ratings for Guardian Pharmacy Services have improved, with Wall Street Zen upgrading the stock to a "strong-buy", while Truist Financial raised its price target from $25.00 to $28.00.
  • Institutional investors have shown interest in Guardian Pharmacy Services, with several acquiring new positions and notable increases in holdings, such as a 76.8% increase by the Police & Firemen's Retirement System of New Jersey.
  • Five stocks to consider instead of Guardian Pharmacy Services.

Shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) reached a new 52-week high during trading on Tuesday . The stock traded as high as $28.98 and last traded at $28.72, with a volume of 392473 shares traded. The stock had previously closed at $28.21.

Analyst Ratings Changes

GRDN has been the subject of several recent analyst reports. Wall Street Zen raised shares of Guardian Pharmacy Services from a "hold" rating to a "strong-buy" rating in a research note on Sunday, August 17th. Raymond James Financial set a $28.00 target price on shares of Guardian Pharmacy Services and gave the stock an "outperform" rating in a research note on Wednesday, May 14th. Finally, Truist Financial reiterated a "buy" rating and issued a $28.00 price target (up previously from $25.00) on shares of Guardian Pharmacy Services in a report on Monday, May 19th. Three equities research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Guardian Pharmacy Services presently has a consensus rating of "Buy" and a consensus target price of $25.67.

Check Out Our Latest Research Report on GRDN

Guardian Pharmacy Services Stock Performance

The firm has a market cap of $1.82 billion and a price-to-earnings ratio of -18.89. The company's fifty day moving average is $22.74 and its two-hundred day moving average is $22.11.

Hedge Funds Weigh In On Guardian Pharmacy Services

Hedge funds and other institutional investors have recently made changes to their positions in the business. GAMMA Investing LLC acquired a new position in shares of Guardian Pharmacy Services during the 1st quarter valued at $170,000. BNP Paribas Financial Markets acquired a new position in shares of Guardian Pharmacy Services during the 4th quarter valued at $37,000. Parkside Financial Bank & Trust acquired a new position in shares of Guardian Pharmacy Services during the 2nd quarter valued at $41,000. Raymond James Financial Inc. acquired a new position in Guardian Pharmacy Services in the 2nd quarter worth $43,000. Finally, Police & Firemen s Retirement System of New Jersey lifted its holdings in Guardian Pharmacy Services by 76.8% in the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 2,444 shares of the company's stock worth $52,000 after buying an additional 1,062 shares in the last quarter.

Guardian Pharmacy Services Company Profile

(Get Free Report)

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Guardian Pharmacy Services Right Now?

Before you consider Guardian Pharmacy Services, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.

While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.